Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults

2016/03/31 by Derek Y. Hsu, Joaquin Brieva, Joaquin C. Brieva +2 · 27 citations
Medicine · #Drug-Induced Adverse Reactions #Urticaria and Related Conditions #Autoimmune Bullous Skin Diseases

paper · pdf · doi:10.1016/j.jid.2016.03.023

Citations

• Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Cited by

• The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK
• Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States
• Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. [europepmc]
• An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity. [europepmc]
• Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System. [europepmc]
• Antibiotic allergy. [europepmc]
• Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10. [europepmc]
• Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea. [europepmc]
• Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review. [europepmc]
• Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. [europepmc]
• Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis. [europepmc]
• Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction. [europepmc]
• Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. [europepmc]
• Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis. [europepmc]
• Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study. [europepmc]
• Skin Resident Memory T Cells May Play Critical Role in Delayed-Type Drug Hypersensitivity Reactions. [europepmc]
• Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. [europepmc]
• A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine. [europepmc]
• Culprit Medications and Risk Factors Associated with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case-Control Study. [europepmc]
• Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome. [europepmc]
• Skin Inflammation with a Focus on Wound Healing. [europepmc]
• Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020. [europepmc]
• A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. [europepmc]
• Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. [europepmc]
• Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome. [europepmc]
• Severe cutaneous adverse reactions. [europepmc]
• Update on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management. [europepmc]